scispace - formally typeset
G

Guylène Page

Researcher at University of Poitiers

Publications -  70
Citations -  7555

Guylène Page is an academic researcher from University of Poitiers. The author has contributed to research in topics: Protein kinase R & PI3K/AKT/mTOR pathway. The author has an hindex of 29, co-authored 68 publications receiving 6813 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease

TL;DR: Findings demonstrate that the mainly anti‐apoptotic mTOR/p70S6k signalling is altered in cellular and transgenic models of Alzheimer's disease and in peripheral cells of patients, and could contribute to the pathogenesis of the disease.
Journal ArticleDOI

Tyk2/STAT3 Signaling Mediates β-Amyloid-Induced Neuronal Cell Death: Implications in Alzheimer's Disease

TL;DR: The involvement of the transcription factor signal transducer and activator of transcription 3 (STAT3) in mediating Aβ-induced neuronal death and the potential involvement of Tyk2/STAT3 signaling in AD pathophysiology are reported.
Journal ArticleDOI

Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.

TL;DR: It is demonstrated that two double-stranded RNA-dependent protein kinase blockers attenuate, in human neuroblastoma cells, beta-amyloid peptide toxicity evaluated by caspase 3 assessment and could represent a new therapeutic target for neuroprotection.
Journal ArticleDOI

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases.

TL;DR: This article proposes to review the significant papers concerning the role of polyphenols on aggregation and disaggregation of amyloid peptide, tau, α-synuclein, synphilin-1, suggesting that these compounds could be useful in the treatments in Alzheimer's and Parkinson's diseases.